Skip to main content

Published locations for HER2-positive breast cancer: Trastuzumab biosimilar shows comparable long-term survival

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HER2-positive breast cancer: Trastuzumab biosimilar shows comparable long-term survival

User login

  • Reset your password
  • /content/her2-positive-breast-cancer-trastuzumab-biosimilar-shows-comparable-long-term-survival
  • /hematology-oncology/article/243654/breast-cancer/her2-positive-breast-cancer-trastuzumab-biosimilar
  • /breast-cancer-icymi/article/243654/breast-cancer/her2-positive-breast-cancer-trastuzumab-biosimilar